China’s latest long-endurance stealth unmanned aerial vehicle (UAV), the CH-7, has completed its maiden flight, further expanding Beijing’s rapidly growing arsenal of autonomous weapons. State ...

The UK chancellor, Rachel Reeves, delivered a budget on Wednesday that contained few surprises, least of all the decision to freeze tax thresholds. After ruling out an income tax hike at the last ...

Jaime Tugayev is the News Editor for DualShockers with over a decade of experience, and a much longer love for fantasy, shooters and strategy games. Now you see me, now you don't. Please ignore the ...

Today Briony is back with a review of Razer's Blade Stealth 13 in Mercury White. This is a premium ultrabook, priced at £1500, but Briony loves the design and also tests out its gaming capabilities.

Flashy wealth is out. Quiet wealth is in. In 2025, it's not the person posting luxury vacations on Instagram who's winning; it's the one with a paid-off mortgage and maxed-out retirement accounts. The ...

After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy ...

Bigger is always better in computing. Just maybe don't try and tell that to the SFF guys with their Fractal Terras and neat cable routing. But in these terms the 18-inch gaming laptop is a desktop ...

The FDA has denied Stealth BioTherapeutics’ request to reconsider its complete response letter, leaving the fate of the biotech and its investigational treatment for an ultrarare genetic disease ...

The B-2s, valued at roughly $2 billion a piece, are known not only for their stealth technology, but for their ability to fly long range. Its design and materials limit its ability to be detected by ...

May 29 (Reuters) - Privately held Stealth BioTherapeutics said on Thursday the U.S. Food and Drug Administration had declined to approve its therapy for an ultra-rare condition called Barth Syndrome, ...

Stealth BioTherapeutics’ 16.5-month priority review cycle has ended in rejection. After delays, Stealth said the FDA turned down its request but set out a path to accelerated approval, leading the ...

China is fast-tracking delivery of its advanced J-35A fifth-generation stealth fighters to Pakistan, with the first batch expected by early 2026, according to senior diplomatic and military sources ...